WCM Investment Management
RVMD icon

WCM Investment Management’s Revolution Medicines RVMD Stock Holding History

WCM Investment Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.2M Sell
58,074
-46,915
-45% -$6.85M 0.02% 148
2026
Q1 		$9.73M Sell
104,989
-12,226
-10% -$1.23M 0.02% 151
2025
Q4 		$9.34M Sell
117,215
-136,162
-54% -$8.93M 0.02% 155
2025
Q3 		$11.7M Sell
253,377
-4,437
-2% -$174K 0.02% 136
2025
Q2 		$9.52M Buy
257,814
+11,817
+5% +$454K 0.02% 148
2025
Q1 		$9.19M Buy
245,997
+88,520
+56% +$3.59M 0.02% 146
2024
Q4 		$6.8M Buy
+157,477
New +$7.95M 0.02% 164

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

WCM Investment Management's RVMD Position: Q2 2026 in Review

WCM Investment Management reduced its Revolution Medicines (RVMD) stake by 45% in Q2 2026, selling an estimated $6.85M and leaving 58,074 shares worth $11.2M. The position accounts for 0.02% of the portfolio, ranked #148.

WCM Investment Management first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.7M in Q3 2025. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • WCM Investment Management held 58,074 shares of Revolution Medicines worth $11.2M as of Q2 2026.
  • WCM Investment Management sold 46,915 Revolution Medicines shares in Q2 2026, an estimated $6.85M.
  • Revolution Medicines made up 0.02% of WCM Investment Management's portfolio in Q2 2026, its #148 holding.
  • WCM Investment Management first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • WCM Investment Management's Revolution Medicines position peaked at $11.7M in Q3 2025.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on WCM Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.